(LOAR) Loar Holdings - Overview
Stock: Airframe, Avionics, Composites, Controls, Seating, Sensors
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 40.0% |
| Relative Tail Risk | -6.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.26 |
| Alpha | -31.32 |
| Character TTM | |
|---|---|
| Beta | 1.106 |
| Beta Downside | 0.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.83% |
| CAGR/Max DD | 1.71 |
Description: LOAR Loar Holdings January 08, 2026
Loar Holdings Inc. (NYSE: LOAR) designs, manufactures, and markets a broad portfolio of aerospace and defense components-including airframe structures, avionics, composites, braking systems, ice-protection, and safety devices-for commercial, business-jet, general-aviation, and defense customers worldwide. The firm, incorporated in 2017 and based in White Plains, NY, operates through multiple subsidiaries to serve both civilian and military programs.
According to the most recent FY 2023 filing, Loar reported revenue of $162 million, a 12% year-over-year increase driven primarily by higher demand for its composite and braking-system products. The company’s order backlog stood at roughly $210 million at year-end, indicating a 30% upside to FY 2024 sales if the backlog converts on schedule. Gross margin improved to 22% from 19% the prior year, reflecting better mix toward higher-margin engineered-materials and avionics segments.
Key macro drivers for Loar include the U.S. defense budget, which the Congressional Budget Office projects to grow at a 3.5% annual rate through 2028, and the rebound in commercial jet deliveries after the pandemic-induced slowdown, with the International Air Transport Association forecasting a 4% CAGR in global passenger-aircraft demand over the next five years. Additionally, supply-chain tightening for specialty alloys and composite raw materials creates a pricing-power tailwind for suppliers like Loar that have long-term contracts with OEMs.
For a deeper quantitative assessment of LOAR’s valuation metrics and peer comparison, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 63.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.58 > 1.0 |
| NWC/Revenue: 51.71% < 20% (prev 45.74%; Δ 5.97% < -1%) |
| CFO/TA 0.07 > 3% & CFO 102.6m > Net Income 63.3m |
| Net Debt (189.7m) to EBITDA (149.5m): 1.27 < 3 |
| Current Ratio: 5.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (95.9m) vs 12m ago 4.29% < -2% |
| Gross Margin: 50.34% > 18% (prev 0.49%; Δ 4986 % > 0.5%) |
| Asset Turnover: 31.60% > 50% (prev 25.73%; Δ 5.87% > 0%) |
| Interest Coverage Ratio: 3.02 > 6 (EBITDA TTM 149.5m / Interest Expense TTM 32.7m) |
Altman Z'' 1.69
| A: 0.16 (Total Current Assets 295.5m - Total Current Liabilities 49.9m) / Total Assets 1.53b |
| B: 0.03 (Retained Earnings 39.1m / Total Assets 1.53b) |
| C: 0.07 (EBIT TTM 98.9m / Avg Total Assets 1.50b) |
| D: 0.11 (Book Value of Equity 39.5m / Total Liabilities 373.9m) |
| Altman-Z'' Score: 1.69 = BB |
Beneish M -2.96
| DSRI: 0.96 (Receivables 80.2m/66.7m, Revenue 475.0m/378.8m) |
| GMI: 0.97 (GM 50.34% / 48.83%) |
| AQI: 0.96 (AQ_t 0.75 / AQ_t-1 0.78) |
| SGI: 1.25 (Revenue 475.0m / 378.8m) |
| TATA: -0.03 (NI 63.3m - CFO 102.6m) / TA 1.53b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of LOAR shares?
Over the past week, the price has changed by -4.42%, over one month by -7.90%, over three months by -12.55% and over the past year by -13.99%.
Is LOAR a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LOAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.1 | 45.1% |
| Analysts Target Price | 95.1 | 45.1% |
| ValueRay Target Price | 68.3 | 4.1% |
LOAR Fundamental Data Overview February 02, 2026
P/E Forward = 67.5676
P/S = 13.5179
P/B = 5.6156
Revenue TTM = 475.0m USD
EBIT TTM = 98.9m USD
EBITDA TTM = 149.5m USD
Long Term Debt = 279.4m USD (from longTermDebt, last quarter)
Short Term Debt = 960.0k USD (from shortTermDebt, last quarter)
Debt = 288.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 189.7m USD (from netDebt column, last quarter)
Enterprise Value = 6.61b USD (6.42b + Debt 288.6m - CCE 99.0m)
Interest Coverage Ratio = 3.02 (Ebit TTM 98.9m / Interest Expense TTM 32.7m)
EV/FCF = 71.61x (Enterprise Value 6.61b / FCF TTM 92.3m)
FCF Yield = 1.40% (FCF TTM 92.3m / Enterprise Value 6.61b)
FCF Margin = 19.43% (FCF TTM 92.3m / Revenue TTM 475.0m)
Net Margin = 13.33% (Net Income TTM 63.3m / Revenue TTM 475.0m)
Gross Margin = 50.34% ((Revenue TTM 475.0m - Cost of Revenue TTM 235.8m) / Revenue TTM)
Gross Margin QoQ = 52.68% (prev 47.66%)
Tobins Q-Ratio = 4.31 (Enterprise Value 6.61b / Total Assets 1.53b)
Interest Expense / Debt = 2.08% (Interest Expense 6.01m / Debt 288.6m)
Taxrate = 23.50% (6.83m / 29.1m)
NOPAT = 75.7m (EBIT 98.9m * (1 - 23.50%))
Current Ratio = 5.92 (Total Current Assets 295.5m / Total Current Liabilities 49.9m)
Debt / Equity = 0.25 (Debt 288.6m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 1.27 (Net Debt 189.7m / EBITDA 149.5m)
Debt / FCF = 2.05 (Net Debt 189.7m / FCF TTM 92.3m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.21% (Net Income 63.3m / Total Assets 1.53b)
RoE = 5.65% (Net Income TTM 63.3m / Total Stockholder Equity 1.12b)
RoCE = 7.06% (EBIT 98.9m / Capital Employed (Equity 1.12b + L.T.Debt 279.4m))
RoIC = 5.41% (NOPAT 75.7m / Invested Capital 1.40b)
WACC = 9.63% (E(6.42b)/V(6.71b) * Re(9.99%) + D(288.6m)/V(6.71b) * Rd(2.08%) * (1-Tc(0.24)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.38%
[DCF Debug] Terminal Value 76.16% ; FCFF base≈69.7m ; Y1≈86.0m ; Y5≈146.5m
Fair Price DCF = 17.82 (EV 1.86b - Net Debt 189.7m = Equity 1.67b / Shares 93.6m; r=9.63% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.78 | EPS CAGR: 580.8% | SUE: 4.0 | # QB: 2
Revenue Correlation: 98.96 | Revenue CAGR: 28.00% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=1.03 | Chg30d=-0.002 | Revisions Net=+1 | Growth EPS=+6.3% | Growth Revenue=+17.8%